Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$72,240
-$3,741,024 QoQ
Shares Held
3,000
-97.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,578
of 2,821 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOCHK Asset Management Ltd holds $32,542,832 across 7 Drug Manufacturers - General names. PFE ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
41,590 | $10,465,707 | |
| 2 | LLY |
ELI LILLY & Co
|
6,610 | $7,928,232 | |
| 3 | MRK |
Merck & Co., Inc.
|
44,360 | $5,700,260 | |
| 4 | JNJ |
Johnson & Johnson
|
15,290 | $3,883,201 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
19,800 | $2,501,532 | |
| 6 | AMGN |
Amgen Inc
|
5,500 | $1,991,660 | |
| 7 | PFE |
Pfizer Inc
This page
|
3,000 | $72,240 |
All Filings in PFE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,240 | 3,000 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $3,813,264 | 135,800 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $976,080 | 39,200 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $33,124 | 1,300 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||